Biden Pushes for Medicare, Medicaid to Cover Weight-Loss Drugs
TL;DR Summary
The Biden administration has proposed a plan to include coverage for obesity drugs under Medicare and Medicaid, aiming to address the growing obesity epidemic and improve healthcare outcomes for millions of Americans.
- Obesity Drugs Would Be Covered by Medicare and Medicaid Under Biden Proposal The New York Times
- Biden proposes Medicare and Medicaid cover costly weight-loss drugs for millions of obese Americans The Associated Press
- 7.4 million Americans could gain Medicare or Medicaid coverage for anti-obesity drugs under Biden proposal CNN
- Demand for weight loss drugs like Ozempic and Wegovy fueling employer health care costs Fortune
- Biden wants Medicare, Medicaid to cover pricey weight-loss drugs such as Wegovy USA TODAY
Reading Insights
Total Reads
0
Unique Readers
1
Time Saved
0 min
vs 1 min read
Condensed
-10%
29 → 32 words
Want the full story? Read the original article
Read on The New York Times